Hyperion DeFi (NASDAQ:HYPD – Get Free Report) and Radian Group (NYSE:RDN – Get Free Report) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings and dividends.
Profitability
This table compares Hyperion DeFi and Radian Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hyperion DeFi | 416.56% | -11.62% | -9.96% |
| Radian Group | 32.60% | 13.65% | 6.91% |
Volatility & Risk
Hyperion DeFi has a beta of 2.51, suggesting that its stock price is 151% more volatile than the S&P 500. Comparatively, Radian Group has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.
Insider & Institutional Ownership
25.8% of Hyperion DeFi shares are owned by institutional investors. Comparatively, 95.3% of Radian Group shares are owned by institutional investors. 7.5% of Hyperion DeFi shares are owned by insiders. Comparatively, 2.0% of Radian Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Hyperion DeFi and Radian Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hyperion DeFi | 1 | 1 | 2 | 0 | 2.25 |
| Radian Group | 0 | 3 | 6 | 0 | 2.67 |
Hyperion DeFi presently has a consensus target price of $9.82, indicating a potential upside of 211.90%. Radian Group has a consensus target price of $43.14, indicating a potential upside of 28.29%. Given Hyperion DeFi’s higher probable upside, analysts clearly believe Hyperion DeFi is more favorable than Radian Group.
Earnings & Valuation
This table compares Hyperion DeFi and Radian Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hyperion DeFi | $810,000.00 | 60.43 | -$45.31 million | ($6.53) | -0.48 |
| Radian Group | $1.20 billion | 3.72 | $582.64 million | $3.89 | 8.65 |
Radian Group has higher revenue and earnings than Hyperion DeFi. Hyperion DeFi is trading at a lower price-to-earnings ratio than Radian Group, indicating that it is currently the more affordable of the two stocks.
Summary
Radian Group beats Hyperion DeFi on 9 of the 14 factors compared between the two stocks.
About Hyperion DeFi
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
About Radian Group
Radian Group Inc., together with its subsidiaries, engages in the mortgage and real estate services business in the United States. It operates through two segments, Mortgage Insurance and Homegenius segments. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans; and other credit risk management solutions, including contract underwriting. The Homegenius segment offers title services, including a suite of insurance and non-insurance titles; tax and title data, centralized recording, document retrieval, and default curative title services; deed and property reports; closing and settlement services; mortgage underwriting and processing; escrow; appraisal management; and real estate brokerage. This segment also provides real estate valuation products and services; asset management services for managing real estate owned properties, which includes a web-based workflow solution; and a suite of real estate technology products and services to facilitate real estate transactions, such as proprietary platforms as a service solution. It serves mortgage originators, such as mortgage bankers, commercial banks, savings institutions, credit unions, and community banks; and consumers, mortgage lenders, mortgage and real estate investors, government-sponsored enterprises, real estate brokers and agents, and corporations for their employees. The company was formerly known as CMAC Investment Corp. and changed its name to Radian Group Inc. in June 1999. Radian Group Inc. was founded in 1977 and is headquartered in Wayne, Pennsylvania.
Receive News & Ratings for Hyperion DeFi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion DeFi and related companies with MarketBeat.com's FREE daily email newsletter.
